Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 1:45 PM ET

Diversified Consumer Services

Company Overview of University of Rochester

Company Overview

University of Rochester is an educational institution offering degree programs at the bachelors, masters, and doctoral level. The schools of the university include William E. Simon Graduate School of Business Administration; Margaret Warner Graduate School of Education and Human Development; School of Medicine and Dentistry; School of Nursing; Strong Memorial Hospital; Golisano Children's Hospital; Eastman Dental Center; Laboratory for Laser Energetic; and Center for Optoelectronics and Imaging. University of Rochester was established in 1850 and is based in Rochester, New York. The university has endowment assets worth $1298 million.

601 Elmwood Ave

Rochester, NY 14642-0001

United States

Founded in 1851

Phone:

585-275-2121

Fax:

585-461-4595

Key Executives for University of Rochester

President
Age: 64
Professor of Finance and Statistics
Age: 64
Compensation as of Fiscal Year 2014.

University of Rochester Key Developments

Panther Biotechnology, Inc. Enters into Global License Agreement with University of Rochester

Panther Biotechnology Inc. announced that it has entered into an exclusive global license agreement with the University of Rochester. Under the terms of the agreement, Panther has licensed from the University of Rochester, the rights to develop and commercialize a first in class new chemical entity with demonstrated powerful anti-leukemia activity. The licensed compound, called TDZD-8, is a small molecule engineered to kill leukemic stem cells. TDZD-8 has demonstrated broad and selective in vitro activity against many different types of leukemia. In addition, TDZD-8 has no significant toxicity in normal hematopoietic stem cells. TDZD-8 is a kinase inhibitor and induces oxidative stress, causing its striking ability to induce the leukemia cells to die after less than 2 hours of exposure to the drug.

University of Rochester Presents at AVCJ Private Equity & Venture Forum - Australia & New Zealand 2015, Mar-04-2015

University of Rochester Presents at AVCJ Private Equity & Venture Forum - Australia & New Zealand 2015, Mar-04-2015 . Venue: The Westin Sydney, No.1 Martin Place, Sydney, NSW 2000, Australia.

University of Rochester Receives Contract for HIV Risk Reduction for Women Reporting Intimate Partner Violence

University of Rochester was awarded contract for HIV risk reduction for women reporting intimate partner violence. The contract was signed on Jan. 26, 2014 and the value of the contract is $154,243.

Similar Private Companies By Industry

Company Name Region
O C S Security Inc United States
Manufacturer-Spas & Other Products United States
Stanley Steemer International, Inc. United States
FasTracKids International, Ltd. United States
Cognotion, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of Rochester, please visit www.rochester.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.